References
1 New address: Department of Organic Chemistry, C. C., Castilla-La Mancha University, 13071 Ciudad Real, Spain. Email: maherrer@uclm.es.
2
Dolle RE.
J. Comb. Chem.
2003,
5:
693
3
Curran DP.
Angew. Chem. Int. Ed.
1998,
37:
1175
4
Ley SV.
Baxendale IR.
Nat. Rev. Drug Discov.
2002,
1:
573
5
Larhed M.
Hallberg A.
Drug Discov. Today
2001,
6:
406
6
Lew A.
Krutzik PO.
Hart ME.
Chamberlin AR.
J. Comb. Chem.
2002,
4:
95
7
Kaiser N.-FK.
Hallberg A.
Larhed M.
J. Comb. Chem.
2002,
4:
109
8
Georgsson J.
Hallberg A.
Larhed M.
J. Comb. Chem.
2003,
5:
350
9
Wannberg J.
Larhed M.
J. Org. Chem.
2003,
68:
5750
10
Yamazaki K.
Kondo Y.
J. Comb. Chem.
2004,
6:
121
11
Paulsen H.
Stoye D. In
The Chemistry of Amides
Zabicky J.
Interscience Publishers;
London, New York:
1970.
p.517-600
12
Marquis RW.
Ann. Rep. Med. Chem.
2000,
35:
309
13
Hidaka K.
Kimura T.
Hayashi Y.
McDaniel KF.
Dekhtyar T.
Colletti L.
Kiso Y.
Bioorg. Med. Chem. Lett.
2003,
13:
93
14
Kraft A.
Liebigs Ann. Recl.
1997,
1463
15
Brain CT.
Brunton SA.
Synlett
2001,
382
16
Larhed M.
Moberg C.
Hallberg A.
Acc. Chem. Res.
2002,
35:
717
17 To increase the yields of thermally labile products, Strauss has used the steep heating and cooling profiles associated with microwave heating and efficient cooling. See: Strauss CR.
Trainor RW.
Aust. J. Chem.
1995,
48:
1665
18
Herrmann WA.
Bohm VPW.
Reisinger C.-P.
J. Organomet. Chem.
1999,
576:
23
19
Netherton MR.
Fu GC.
Org. Lett.
2001,
3:
4295
20
Horvath IT.
Acc. Chem. Res.
1998,
31:
641
21
de Wolf E.
van Koten G.
Deelman B.-J.
Chem. Soc. Rev.
1999,
28:
37
22
Barthel-Rosa LP.
Gladysz JA.
Coord. Chem. Rev.
1999,
190-192:
587
23
Olofsson K.
Kim S.-Y.
Larhed M.
Curran DP.
Hallberg A.
J. Org. Chem.
1999,
64:
4539
24 For an example of a recoverable fluorous catalyst in Heck chemistry see: Curran DP.
Fischer K.
Moura-Letts G.
Synlett
2004,
1379
25
N
-(4-Methoxy)benzoyl-
N
′-phenylacetylhydrazine (
3b). Colorless solid; mp 153-154 ºC. LC-MS t
R = 4.26 min,
m/z = 285 [M + H+]. 1H NMR (400 MHz, CD3OD): δ = 3.58 (s, 2 H), 3.80 (s, 3 H), 6.94 (AA′XX ′, 2 H), 7.15-7.34 (m, 5 H), 7.79 (AA′XX ′, 2 H) ppm. 13C NMR (100.5 MHz, CD3OD): δ = 43.0, 57.6, 116.5 (2), 127.2, 129.6, 131.2 (2), 131.9 (2), 132.2 (2), 137.9, 166.0, 170.6, 174.9 ppm. Anal. Calcd for C16H16N2O3 (%): C, 67.59; H, 5.67; N, 9.85. Found: C, 67.40; H, 5.78; N, 9.70.
N
-(4-Methoxy)benzoyl-
N
′-
tert
-butoxycarbonylhydrazine (
3c). Colorless solid; mp 148-149 °C. LC-MS t
R = 4.58 min, m/z = 267 [M + H+]. 1H NMR (400 MHz, CD3CN): δ = 1.44 (s, 9 H), 3.83 (s, 3 H), 6.95 (AA′XX ′, 2 H), 7.76 (AA′XX ′, 2 H) ppm. 13C NMR (100.5 MHz, CD3CN): δ = 28.3 (3), 56.1, 81.2, 114.7 (2), 125.8, 130.1 (2), 156.5, 163.5, 167.4 ppm. Anal. Calcd for C13H18N2O4 (%): C, 58.64; H, 6.81; N, 10.52. Found: C, 58.54; H, 6.72; N, 10.66.
N
-(4-Methyl)benzoyl-
N
′-phenylacetylhydrazine (
3e). Colorless solid; mp 175-176 °C. LC-MS t
R = 4.71 min,
m/z = 269 [M + H+]. 1H NMR (400 MHz, CD3OD): δ = 2.39 (s, 2 H), 3.63 (s, 2 H), 7.20-7.39 (m, 5 H), 7.76 (AA′XX ′, 2 H) ppm. 13C NMR (100.5 MHz, CD3OD): δ = 21.5, 41.7, 127.9, 128.7 (2), 129.5 (2), 129.8 (2), 130.1, 130.2 (2), 130.6, 136.2, 144.1, 169.2, 173.1 ppm. Anal. Calcd for C16H16N2O2 + 0.4H2O (%): C, 69.75; H, 6.15; N, 10.17. Found: C, 69.71; H, 6.04; N, 10.11.
N
-(4-Methyl)benzoyl-
N
′-
tert
-butoxycarbonylhydrazine (
3f). Colorless solid; mp 153-154 °C. LC-MS t
R = 5.05 min, m/z = 251 [M + H+]. 1H NMR (400 MHz, CDCl3): δ = 1.48 (s, 9 H), 2.38 (s, 3 H), 7.20 (AA′XX ′, 2 H), 7.70 AA′XX ′, 2 H) ppm. 13C NMR (100.5 MHz, CDCl3): δ = 21.7, 28.3 (3), 82.1, 127.4 (2), 129.1, 129.4 (2), 142.9, 155.9, 167.0 ppm. Anal. Calcd for C13H18N2O3 (%): C, 62.38; H, 7.25; N, 11.19. Found: C, 62.22; H, 7.11; N, 11.06.
N
-(2-Methyl)benzoyl-
N
′-phenylacetylhydrazine (
3h). Colorless solid; mp 174-175 °C. LC-MS t
R = 4.40 min,
m/z = 269 [M + H+]. 1H NMR (400 MHz, CD3OD): δ = 2.40 (s, 3 H), 3.60 (s, 2 H), 7.17-7.36 (m, 8 H), 7.43 (dd, J = 7.7, 1.2 Hz, 1 H, ArH) ppm. 13C NMR (100.5 MHz, CD3OD): δ = 18.3, 40.3, 125.4, 126.7, 127.2, 128.2, 128.9, 130.2, 130.5, 134.0, 134.9, 136.4, 165.5, 171.6 ppm. Anal. Calcd for C16H16N2O2 + 0.5H2O (%): C, 69.30; H, 6.18; N, 10.10. Found: C, 69.45; H, 6.19; N, 9.96.
N
-Phenylacetyl-
N
′-(4-trifluoromethyl)benzoylhydrazine (
3k). Colorless solid; mp 195-196 °C. LC-MS t
R = 5.92 min, m/z = 323 [M + H+]. 1H NMR (400 MHz, CD3OD): δ = 3.61 (s, 2 H), 7.15-7.35 (m, 5 H), 7.76 (AA′XX ′, 2 H), 7.99 (AA′XX ′, 2 H) ppm. Anal. Calcd for C16H13F3N2O2 (%): C, 59.63; H, 4.07; N, 8.69. Found: C, 59.41; H, 3.96; N, 8.59.
N
-
tert
-Butoxycarbonyl-
N
′-(4-trifluoromethyl)-benzoylhydrazine (
3l). Colorless solid; mp 143-144 °C. LC-MS t
R = 6.29 min, m/z = 305 [M + H+]. 1H NMR (400 MHz, CD3OD): δ = 1.45 (s, 9 H), 7.80 (AA′XX ′, 2 H), 7.94 (AA′XX ′, 2 H) ppm. Anal. Calcd for C13H15F3N2O3 (%): C, 51.32; H, 4.97; N, 9.21. Found: C, 51.07; H, 5.06; N, 9.35.
26
2-Phenyl-5-(4-trifluoromethyl)phenyl-1,3,4-oxadiazole (
6). Colorless solid; mp 151-152 °C. LC-MS (4 mL/min, 0-70% MeCN in H2O, 8 min gradient, ESI+) t
R = 6.91 min, m/z = 291 [M + H+]. 1H NMR (400 MHz, CDCl3): δ = 7.50-7.60 (m, 3 H), 7.80 (AA′XX ′, 2 H), 8.16 (dd, J = 7.9 and 1.7 Hz, 2 H), 8.27 (AA′XX ′, 2 H). Anal. Calcd for C15H9F3N2O (%): C, 62.07; H, 3.13; N, 9.65. Found: C, 62.08; H, 3.18; N, 9.73.